Details of RareLED ID Assay_1040 |
Primary information | |
---|---|
GENE | NAGLU |
NUMBER OF ASSAY | 23 |
ASSAY IDs | 364924 453057 453052 453046 364923 453056 453055 453054 453053 453051 453050 453049 453048 453047 453045 453044 453043 364926 364925 1314806 453058 1314807 330955 |
Assay Name | 1. Inhibition of human Placental beta-N-acetylglucosaminidase,2. Competitive inhibition of human placenta beta-N-acetylglucosaminidase by pNP-GlcNAc substrate hydrolysis assay,3. Mixed type inhibition of human placenta beta-N-acetylglucosaminidase by pNP-GlcNAc substrate hydrolysis assay,4. Inhibition of human placenta beta-N-acetylglucosaminidase by pNP-GlcNAc substrate hydrolysis assay,5. Inhibition of bovine kidney beta-N-acetylglucosaminidase,6. Competitive inhibition of Penicillium oxalicum beta-N-acetylglucosaminidase by pNP-GlcNAc substrate hydrolysis assay,7. Competitive inhibition of Aspergillus oryzae beta-N-acetylglucosaminidase by pNP-GlcNAc substrate hydrolysis assay,8. Competitive inhibition of jack bean beta-N-acetylglucosaminidase by pNP-GlcNAc substrate hydrolysis assay,9. Noncompetitive inhibition of bovine kidney beta-N-acetylglucosaminidase by pNP-GlcNAc substrate hydrolysis assay,10. Mixed type inhibition of Penicillium oxalicum beta-N-acetylglucosaminidase by pNP-GlcNAc substrate hydrolysis assay,11. Noncompetitive inhibition of Aspergillus oryzae beta-N-acetylglucosaminidase by pNP-GlcNAc substrate hydrolysis assay,12. Competitive inhibition of Spodoptera litura beta-N-acetylglucosaminidase by pNP-GlcNAc substrate hydrolysis assay,13. Inhibition of jack bean beta-N-acetylglucosaminidase by pNP-GlcNAc substrate hydrolysis assay,14. Inhibition of bovine kidney beta-N-acetylglucosaminidase by pNP-GlcNAc substrate hydrolysis assay,15. Inhibition of Penicillium oxalicum beta-N-acetylglucosaminidase by pNP-GlcNAc substrate hydrolysis assay,16. Inhibition of Aspergillus oryzae beta-N-acetylglucosaminidase by pNP-GlcNAc substrate hydrolysis assay,17. Inhibition of Spodoptera litura beta-N-acetylglucosaminidase by pNP-GlcNAc substrate hydrolysis assay,18. Inhibition of Escherichia coli beta-glucuronidase,19. Inhibition of bovine liver beta-glucuronidase,20. Inhibition of beta-hexosaminidase alpha in human skin fibroblast lysate using 4-MU-N-acetyl-beta-D-glucosaminide-6-sulfate sodium salt as substrate assessed as 4-MU liberation by fluorescence assay,21. Competitive inhibition of bovine kidney beta-N-acetylglucosaminidase by pNP-GlcNAc substrate hydrolysis assay,22. Inhibition of beta-hexosaminidase alpha/beta in human skin fibroblast lysate using 4-MU-(2-acetamido-2-deoxy)-beta-D-glucopyranoside as substrate assessed as 4-MU liberation by fluorescence assay,23. Inhibition of human family 84 O-GLcNAcase |
ACTIVITY | Substance BioActivity: 1 Tested Substance BioActivity: 1 Active, 1 Activity <= 1 nM, 1 Activity <= 1 µM, 1 Tested Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested Substance BioActivity: 2 Active, 2 Activity <= 1 µM, 2 Tested Substance BioActivity: 1 Tested Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested Substance BioActivity: 2 Active, 1 Activity <= 1 nM, 2 Activity <= 1 µM, 2 Tested Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested Substance BioActivity: 2 Active, 2 Activity <= 1 µM, 2 Tested Substance BioActivity: 4 Active, 1 Activity <= 1 nM, 2 Activity <= 1 µM, 4 Tested Substance BioActivity: 3 Active, 2 Activity <= 1 µM, 4 Tested Substance BioActivity: 2 Active, 2 Activity <= 1 µM, 2 Tested Substance BioActivity: 2 Active, 2 Activity <= 1 µM, 2 T |